- Presentations
- 6
- Markets
- 1
Revlimid is a brand of Lenalidomide marketed by Celgene, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Lenalidomide
- Brand owner
- Celgene
- Registered in
- United States
- Strengths and forms
- 10 mg capsule, 15 mg capsule, 2.5 mg capsule, 20 mg capsule, 25 mg capsule, 5 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Revlimid 10 mg capsuleOral | Celgene | US FDA | Available on request |
| Revlimid 15 mg capsuleOral | Celgene | US FDA | Available on request |
| Revlimid 2.5 mg capsuleOral | Celgene | US FDA | Available on request |
| Revlimid 20 mg capsuleOral | Celgene | US FDA | Available on request |
| Revlimid 25 mg capsuleOral | Celgene | US FDA | Available on request |
| Revlimid 5 mg capsuleOral | Celgene | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Revlimid
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.